Return
Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy
H
M
N
H
K
D
S
DOI:10.1002/jhbp.70146.png)
Abstract
En 中文
With increasing use of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC), accurate pathological response system is essential. Although the College of American Pathologists (CAP) grading is widely used, its prognostic utility remains limited.
Keywords:
College of American Pathologists grading system
neoadjuvant therapy
pancreatic ductal adenocarcinoma
pathological response system
residual patterns
Journal
IF:
2.8
Papers:
2.0K
Citations:
5.2K
